首页> 美国卫生研究院文献>Springer Open Choice >Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies
【2h】

Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies

机译:GBA相关和偶发性帕金森氏病和痴呆伴路易体的脑溶酶体活动的表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mutations in the GBA gene, encoding the lysosomal hydrolase glucocerebrosidase (GCase), are the most common known genetic risk factor for Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). The present study aims to gain more insight into changes in lysosomal activity in different brain regions of sporadic PD and DLB patients, screened for GBA variants. Enzymatic activities of GCase, β-hexosaminidase, and cathepsin D were measured in the frontal cortex, putamen, and substantia nigra (SN) of a cohort of patients with advanced PD and DLB as well as age-matched non-demented controls (n = 15/group) using fluorometric assays. Decreased activity of GCase (− 21%) and of cathepsin D (− 15%) was found in the SN and frontal cortex of patients with PD and DLB compared to controls, respectively. Population stratification was applied based on GBA genotype, showing substantially lower GCase activity (~ − 40%) in GBA variant carriers in all regions. GCase activity was further significantly decreased in the SN of PD and DLB patients without GBA variants in comparison to controls without GBA variants. Our results show decreased GCase activity in brains of PD and DLB patients with and without GBA variants, most pronounced in the SN. The results of our study confirm findings from previous studies, suggesting a role for GCase in GBA-associated as well as sporadic PD and DLB.Electronic supplementary materialThe online version of this article (10.1007/s12035-018-1090-0) contains supplementary material, which is available to authorized users.
机译:编码溶酶体水解酶葡糖脑苷脂酶(GCase)的GBA基因突变是帕金森氏病(PD)和路易小体(DLB)痴呆的最常见遗传风险因素。本研究旨在对散布的PD和DLB患者不同脑区的溶酶体活性变化进行深入了解,并筛选出GBA变体。在一组晚期PD和DLB患者以及年龄相匹配的非痴呆患者的额叶皮层,壳核和黑质(SN)中测量了GCase,β-己糖胺酶和组织蛋白酶D的酶活性(n = 15 /组)。与对照组相比,PD和DLB患者的SN和额叶皮层中GCase(-21%)和组织蛋白酶D(-15%)的活性降低。基于GBA基因型进行了群体分层,显示所有区域中GBA变异携带者的GCase活性均显着降低(约40%)。与没有GBA变体的对照相比,在没有GBA变体的PD和DLB患者的SN中,GCase活性进一步显着降低。我们的结果显示,PD和DLB患者中有或没有GBA变体的大脑中GCase活性降低,这在SN中最为明显。我们的研究结果证实了先前研究的发现,表明GCase在与GBA有关的以及散发的PD和DLB中的作用。电子补充材料本文的在线版本(10.1007 / s12035-018-1090-0)包含补充材料,可供授权用户使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号